These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 24128410

  • 1. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.
    Koh EJ, El-Gamal MI, Oh CH, Lee SH, Sim T, Kim G, Choi HS, Hong JH, Lee SG, Yoo KH.
    Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410
    [Abstract] [Full Text] [Related]

  • 2. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
    Choi WK, El-Gamal MI, Choi HS, Baek D, Oh CH.
    Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
    [Abstract] [Full Text] [Related]

  • 3. New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line.
    Kim HJ, Cho HJ, Kim H, El-Gamal MI, Oh CH, Lee SH, Sim T, Hah JM, Yoo KH.
    Bioorg Med Chem Lett; 2012 May 01; 22(9):3269-73. PubMed ID: 22460030
    [Abstract] [Full Text] [Related]

  • 4. A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect.
    El-Gamal MI, Khan MA, Abdel-Maksoud MS, Gamal El-Din MM, Oh CH.
    Eur J Med Chem; 2014 Nov 24; 87():484-92. PubMed ID: 25282271
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
    El-Damasy AK, Seo SH, Cho NC, Kang SB, Pae AN, Kim KS, Keum G.
    Eur J Med Chem; 2015 Aug 28; 101():754-68. PubMed ID: 26218653
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives.
    Gamal El-Din MM, El-Gamal MI, Abdel-Maksoud MS, Yoo KH, Oh CH.
    Bioorg Med Chem Lett; 2015 Apr 15; 25(8):1692-1699. PubMed ID: 25801936
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
    El-Gamal MI, Khan MA, Tarazi H, Abdel-Maksoud MS, Gamal El-Din MM, Yoo KH, Oh CH.
    Eur J Med Chem; 2017 Feb 15; 127():413-423. PubMed ID: 28088086
    [Abstract] [Full Text] [Related]

  • 8. New triarylpyrazoles as broad-spectrum anticancer agents: design, synthesis, and biological evaluation.
    El-Gamal MI, Park YS, Chi DY, Yoo KH, Oh CH.
    Eur J Med Chem; 2013 Jul 15; 65():315-22. PubMed ID: 23732996
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI, Jung MH, Lee WS, Sim T, Yoo KH, Oh CH.
    Eur J Med Chem; 2011 Aug 15; 46(8):3218-26. PubMed ID: 21592628
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2.
    Jung MH, El-Gamal MI, Abdel-Maksoud MS, Sim T, Yoo KH, Oh CH.
    Bioorg Med Chem Lett; 2012 Jul 01; 22(13):4362-7. PubMed ID: 22647720
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors.
    Yang W, Chen Y, Zhou X, Gu Y, Qian W, Zhang F, Han W, Lu T, Tang W.
    Eur J Med Chem; 2015 Jan 07; 89():581-96. PubMed ID: 25462267
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.
    El-Gamal MI, Park BJ, Oh CH.
    Eur J Med Chem; 2018 Aug 05; 156():230-239. PubMed ID: 30006168
    [Abstract] [Full Text] [Related]

  • 13. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH, El-Gamal MI, Lee YS, Oh CH.
    Eur J Med Chem; 2011 Dec 05; 46(12):5769-77. PubMed ID: 22033063
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
    Tang Q, Zhao Y, Du X, Chong L, Gong P, Guo C.
    Eur J Med Chem; 2013 Nov 05; 69():77-89. PubMed ID: 24012712
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
    Abdel-Maksoud MS, Kim MR, El-Gamal MI, Gamal El-Din MM, Tae J, Choi HS, Lee KT, Yoo KH, Oh CH.
    Eur J Med Chem; 2015 May 05; 95():453-63. PubMed ID: 25841200
    [Abstract] [Full Text] [Related]

  • 16. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities.
    El-Damasy AK, Lee JH, Seo SH, Cho NC, Pae AN, Keum G.
    Eur J Med Chem; 2016 Jun 10; 115():201-16. PubMed ID: 27017549
    [Abstract] [Full Text] [Related]

  • 17. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.
    Defaux J, Antoine M, Logé C, Le Borgne M, Schuster T, Seipelt I, Aicher B, Teifel M, Günther E, Gerlach M, Marchand P.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3748-52. PubMed ID: 25022204
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
    Arafa RK, Hegazy GH, Piazza GA, Abadi AH.
    Eur J Med Chem; 2013 May 15; 63():826-32. PubMed ID: 23584545
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarylpyrazole derivatives possessing arylamides or arylureas moieties.
    Gamal El-Din MM, El-Gamal MI, Abdel-Maksoud MS, Yoo KH, Oh CH.
    Eur J Med Chem; 2016 Aug 25; 119():122-31. PubMed ID: 27155467
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X, Bao G, Wang L, Cheng M, Zhao M, Zhao S, Zhou H, Gong P.
    Bioorg Med Chem; 2016 Mar 15; 24(6):1331-45. PubMed ID: 26897090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.